Related by context. All words. (Click for frequent words.) 70 pharmacogenomics 66 pharmacogenetic 66 pharmacogenetic testing 65 companion diagnostics 65 PGx 65 personalized medicine 62 genomics 62 metabonomics 61 Pharmacogenetics 61 metabolomics 61 epigenetics 61 genomic 60 predictive biomarkers 60 Pharmacogenomics 60 pharmacogenomic 60 translational medicine 60 Theranostics 60 predictive toxicology 60 therapeutic monoclonal antibodies 60 molecular biomarkers 59 pharmacogenomic testing 59 ERYtech 59 molecular profiling 59 therapeutics 59 genomic proteomic 59 biomarker 59 biomarker assays 59 epigenomics 59 investigational therapies 59 biomarker identification 59 epigenetic therapies 58 functional genomics 58 microRNA therapeutics 58 RNA therapeutics 58 anticancer therapies 58 neuropsychiatric diseases 58 Personalized medicine 58 pharmacogenetic tests 58 biomarker discovery 57 genetics genomics 57 ADME Tox 57 theranostics 57 diagnostic biomarkers 57 nutrigenomic 57 nutrigenomics 57 siRNA therapeutics 57 biomarkers 57 proteomics 57 metabolite identification 57 tranilast 57 genomic medicine 57 antiviral compounds 57 therapeutic monoclonal antibody 57 monoclonal antibody therapeutics 57 A3 adenosine receptor 56 vaccinology 56 kinase inhibitors 56 genomic biomarkers 56 immunotherapeutics 56 VKORC1 56 Toxicogenomics 56 KineMed 56 molecular underpinnings 56 NovaBay Aganocide compounds 56 systemic RNAi 56 Stapled Peptide 56 GPCR targets 56 Referenced EEG 56 Epigenetics 56 MEK inhibitors 56 glycomics 56 reverse vaccinology 56 metabolite profiling 56 Celator 56 monoclonal antibody therapies 56 novel therapeutic antibodies 55 prognostic markers 55 diagnostic prognostic 55 biopsychosocial 55 molecularly targeted therapies 55 myeloproliferative disorders 55 GPR# agonists 55 protein biomarker discovery 55 cellular reprogramming 55 molecular pathogenesis 55 toxicogenomics 55 immunotherapeutic approaches 55 CB1 antagonists 55 Zafgen 55 Spiegelmers R 55 alternative RNA splicing 55 ALK inhibitors 55 antiviral therapies 55 resolvins 55 pharmacotherapies 55 Homspera TM 55 ADME properties 55 stem cell therapeutics 55 tiapamil 55 Personalised medicine 55 Liprotamase 55 FoldRx 55 theranostic 55 cMET 55 psychoneuroimmunology 55 eTag assays 55 anti angiogenic drugs 55 anticoagulant reversing agent 55 underlying molecular mechanisms 55 proteomic 55 oligonucleotide therapeutics 55 prognostic biomarkers 55 molecular pathology 55 biologic therapeutics 55 pharmacoeconomic 55 immunology oncology 55 validating biomarkers 55 Alnylam RNAi 55 Ceflatonin 54 Novosom 54 biotherapeutics 54 DNA methylation biomarkers 54 chemoprevention 54 biopharmaceuticals 54 translational neuroscience 54 Curidium 54 protein homeostasis 54 histone methyltransferases HMTs 54 adrenergic regulation 54 genetic underpinnings 54 microRNA biology 54 tumor immunology 54 TLR Therapeutics 54 biobetter 54 immunology 54 kidney urologic 54 Receptos 54 glycobiology 54 oncology 54 oral dnaJP1 54 vitro assay 54 identify protein biomarkers 54 CTLA4 Ig 54 CDK inhibitors 54 peptide therapeutics 54 vascular disrupting agents 54 biochemical profiling 54 Biomarker 54 epigenetic enzymes 54 RNAi therapeutic targeting 54 diagnostic biomarker 54 Amarantus 54 druggable targets 54 PI3K inhibitors 54 Fabry Disease 54 immunological diseases 54 renin inhibitors 54 INS# [001] 54 TheraGenetics 54 Epizyme 54 THR beta agonist 54 CCR5 antagonists 54 genetic polymorphism 54 PARP inhibitors 54 molecular diagnostic 54 Locus Pharmaceuticals 54 AssureRx 54 biomarker validation 54 diagnostic assays 54 PsychoGenics 54 cardio metabolic diseases 54 gefitinib Iressa 54 combinatorial chemistry 54 Pharmacogenomic 54 human microdosing 54 renin inhibition 54 immunologic diseases 54 ActivX 53 Sphingomab TM 53 miRNA therapeutics 53 novel peptide 53 molecular diagnostics 53 selective androgen receptor modulators 53 EGFR HER 53 psychopharmacologic 53 Milnacipran 53 Matthew Meyerson 53 ganaxolone 53 constipation OIC 53 inhibit metastasis 53 multigene 53 BioMAP 53 biomarker assay development 53 Nanobodies R 53 protein misfolding diseases 53 clinical 53 PARP inhibition 53 nutritional genomics 53 druggable target 53 neuroscience 53 NEUGENE R 53 Transcranial Magnetic Stimulation TMS 53 pathogenic mechanisms 53 micro RNA 53 Alnara Pharmaceuticals 53 anti CD# antibodies 53 Catabasis 53 NanoString 53 Therapeutic antibodies 53 Panzem 53 predictive biomarker 53 oral antiviral 53 Jean Jacques Garaud 53 chemical entities NCEs 53 Zacharon 53 Pepscan 53 molecular assays 53 gene expression profiling 53 Personalised Medicine 53 bioinformatic approaches 53 IAP inhibitors 53 p# inhibitor 53 KRAS mutation 53 biologics 53 Nutrigenomics 53 SIgN 53 NuroPro ® 53 Curaxin 53 proteasome inhibitors 53 Corus CAD 53 Factor VIIa 53 integrative genomics 53 metabolic profiling 53 Cancer Vaccines 53 novel RNAi therapeutics 53 genomic profiling 53 Corixa Corporation 53 Nanobody ® 53 thiazolides 53 biomarkers predictive 53 AQUA ® 53 proteomic technologies 53 whole genome sequencing 53 mGluR5 antagonists 53 genetic biomarkers 53 HepDirect R 53 genomic biomarker 53 treating neuropathic pain 53 molecularly targeted 53 P#X# 53 genetics 53 JAK inhibitors 53 immunochemistry 53 CobaCyte 53 ALN PCS 53 Squalamine 53 genomic sequencing 53 SureGene 52 polymerase inhibitors 52 antiviral therapeutics 52 Anticalins ® 52 BGC# 52 immuno oncology 52 metabolomic 52 immatics 52 MediGene focuses 52 psychopharmacology 52 cyclophilin inhibitors 52 macrolide antibiotics 52 SGLT2 inhibitors 52 isoform selective 52 CardioVascular BioTherapeutics 52 Cascade LifeSciences 52 cardio renal 52 biased ligand 52 clinically differentiated 52 Pervasis 52 Haptoglobin 52 psoriasis psoriatic arthritis 52 tumor subtypes 52 ADMETRx 52 therapeutic peptide 52 comparative genomic 52 Supernus Pharmaceuticals 52 HerbalScience 52 Rasagiline 52 anticancer compounds 52 immunoregulation 52 Cylene 52 EndoTAGTM 1 52 toxicogenomic 52 molecular epidemiology 52 selective kinase inhibitors 52 Immunotherapies 52 PDE# inhibitors 52 bosutinib 52 COX enzymes 52 genomics proteomics 52 immunogenetics 52 metagenomics 52 susceptibility genes 52 genes CYP#C# 52 intracellular signaling pathways 52 tumor hypoxia 52 cytotoxics 52 small molecule activators 52 Sudhir Agrawal D.Phil 52 psychopharmacological 52 neuro degenerative diseases 52 transplantation immunology 52 PNT# 52 Pertuzumab 52 ParagonDx 52 multitargeted 52 protein biosynthesis 52 Alessandro Riva 52 therapies 52 biochemical mechanisms 52 endophenotypes 52 antiangiogenic drugs 52 Biomarker Discovery 52 viral pathogenesis 52 rxRNA 52 Preclinical Development 52 aetiology 52 Thiakis 52 breast cancer subtypes 52 therapeutics diagnostics 52 IMA# 52 chemopreventive agents 52 biomarker discovery validation 52 p# inhibitors 52 mimetics 52 lipidomics 52 Antisense 52 novel peptides 52 biocatalysis 52 CellCentric 52 autoimmune inflammatory 52 molecular pathways 52 CureDM 52 PGRN 52 pathogen interactions 52 neuronal nicotinic receptors NNRs 52 Tovaxin ® 52 AMPAKINE 52 imatinib resistance 52 Novel Therapies 52 antifungal agents 52 novel radiopharmaceuticals 52 BioFocus DPI Galapagos 52 NuroPro R 52 anticancer therapeutics 52 metabolomic profiling 52 biologic pathways 52 antitumour 52 interventional therapies 52 Multiferon ® 52 RNAi therapeutic targeting PCSK9 52 Aviptadil 52 RNAi therapeutics 52 novel therapeutics 52 engineered RAP peptides 52 InforSense 52 Symadex 52 molecular oncology 52 Metabolic Disease 52 Cellzome 52 Molecular biology 52 SERMs 52 immunobiology 52 Galenea 52 Senexis 52 Psynova 52 tissue fibrosis 52 myelofibrosis polycythemia vera 52 synthetic lethality 52 therapeutic armamentarium 52 Tolerx 52 neurology immunology 52 antibody therapeutics 52 Evoltra ® 52 SR Pharma 52 heritable diseases 52 HCV protease inhibitors 52 aptamers 52 cell signaling pathways 52 Valdoxan 52 antisense therapeutics 52 Caris MPI 52 antisense drug 52 protein kinase inhibitors 52 miRNA biomarkers 52 molecular cytogenetics 52 therapeutic radiopharmaceuticals 52 Nanobody 52 MAbs 52 infectious autoimmune 52 medicinal chemists 52 miRagen 52 insulin analogues 52 mechanistic insights 51 preclinically 51 genetic determinants 51 PDE7 51 bioinformatics 51 immuno inflammatory diseases 51 VeriStrat 51 Micro RNAs 51 Monoclonal antibody 51 synthetic genomics 51 JAK inhibitor 51 Guanilib 51 aptamer therapeutics 51 pharmacology 51 cancer chemoprevention 51 Regado 51 genomewide 51 metaglidasen 51 enzymology 51 RNAi 51 Fibrocell Science 51 Singulex 51 transcriptomics 51 sickle cell hemoglobin 51 hematological malignancy 51 GI motility disorders 51 stem cell biology 51 Prodarsan R 51 XmAb 51 LNPs 51 pathophysiology 51 antisense oligonucleotides 51 ALN TTR 51 chemoinformatics 51 MDRNA proprietary 51 anesthesiology pharmacology 51 peptide mimetics 51 LentiVector technology 51 BRAF inhibitor 51 diagnostics therapeutics 51 DGAT 51 vitro ADME 51 translational genomics 51 VEGF inhibitors 51 TRV# [001] 51 Prodarsan ® 51 SUTENT ® 51 JAK2 inhibitor 51 translational research 51 neuro imaging 51 immunotherapeutic vaccine 51 HemeScan test 51 CMV vaccine 51 vascular biology 51 EC Cysteamine 51 Quotient Bioresearch 51 HTS assay 51 glycan microarray 51 sirtuin therapeutics 51 Pancreate ™ 51 Inflammatory Diseases 51 STK# [002] 51 leverages Cytokinetics 51 Mipomersen 51 psychotherapies 51 Mutation Analysis 51 OTCBB PWRM.OB 51 deforolimus 51 Dalbavancin 51 Nanobodies ® 51 TBC# 51 DNAPrint TM 51 Velcade bortezomib 51 VitiGam 51 ONCONASE R 51 proteomics genomics 51 Genizon 51 urology oncology 51 antisense inhibitors 51 ProtoKinetix 51 Campath alemtuzumab 51 CCR3 51 BioSeek 51 protein misfolding 51 PDE7 inhibitors 51 lipoprotein metabolism 51 NITD# 51 Semafore 51 therapeutical 51 microRNA miRNA 51 molecular pharmacologist 51 therapeutic regimens 51 gene expression biomarkers 51 molecular mechanisms underlying 51 molecular determinants 51 molecular genetics 51 salivary diagnostics 51 Vilazodone 51 biotherapies 51 molecular neurobiology 51 biologic therapies 51 trastuzumab DM1 T DM1 51 OGeS 51 molecular markers 51 genotyping 51 BIIR 51 EyeGate 51 LNA TM 51 TLR8 51 mAbs 51 Genedata Expressionist ® 51 BACcel 51 DXL# 51 CINQUIL 51 cellular pathways 51 enGene 51 OMAPRO 51 Modrenal 51 DiLA2 51 RNA antagonists 51 personalized immunotherapy 51 pharmacological approaches 51 tubulin inhibitor 51 massively parallel sequencing 51 Adenosine Therapeutics 51 Quanterix 51 DNA methylation patterns 51 histone deacetylase HDAC 51 cardiometabolic 51 molecular diagnostic assays 51 microRNA biomarkers 51 HIV protease inhibitors 51 Biodesix 51 Drug Discovery 51 genomic discoveries 51 Hedgehog inhibitor 51 Dr. Bert Vogelstein 51 Advinus 51 molecular biomarker 51 PPAR gamma agonists 51 SNP genotyping 51 Regado Biosciences 51 molecular biology 51 RNA Interference 51 anticancer therapy 51 EGFR pathway 51 CBLC# 51 Protagen 51 cancer immunotherapy 51 Viprovex TM 51 diseases fat malabsorption 51 Wellstat 51 GPCRs 51 Aquinox 51 DCVax 51 Exelixis XL# 51 SCYNEXIS 51 KL4 surfactant 51 rheumatologic 51 exon skipping 51 SIRT1 activation 51 taste modulators 51 Adnectin 51 HeliScope Sequencer 51 antiplatelet therapies 51 Src inhibitors 51 bardoxolone methyl 51 gepirone ER 51 Zavesca r 51 Lixivaptan 51 including eniluracil ADH 51 Novartis Gleevec 51 cardiometabolic disorders 51 SARMs 51 epigenetic mechanisms 51 oncology therapeutics 51 NNR Therapeutics 51 Dual Opioid TM 51 Zolinza 51 targeting PCSK9 51 pharmacological chaperone 51 Vysis 51 PhaseBio 51 antidiabetic 51 PharmFilm ® 51 Fc fusion proteins 50 Affimed Therapeutics AG 50 echinocandins 50 ddRNAi 50 OHR/AVR# 50 oral salmon calcitonin 50 neuropharmacology 50 AltheaDx 50 serum biomarkers 50 MMP inhibitors 50 OnDose TM 50 miRNA 50 DCVax R 50 small molecule agonists 50 biocatalysts 50 Synageva 50 Monoclonal Antibodies 50 biological pathways 50 siRNA therapeutic 50 OMP #M# 50 CTLA4 Ig product 50 Romidepsin 50 fibrotic disorders 50 OMP #R# 50 oral PTH 50 nanomedicines 50 melanocortin receptors 50 SGLT Inhibitors 50 Personalized Immunotherapy 50 protein therapeutics 50 JAK3 inhibitor 50 Locked Nucleic Acid LNA 50 molecular biology genomics 50 bionanotechnology 50 HSP# inhibitors 50 molecular mechanisms 50 PGxPredict tests 50 Pharmaceutical Profiles 50 Metallophile ™ Technology 50 efficacious therapies 50 immunodiagnostics 50 Genetic variations 50 protein biochip 50 Calibrant 50 mGlu2 3 50 hedgehog pathway 50 AFFiRiS 50 H3 Biomedicine 50 BRAF inhibitors 50 evolutionary genomics 50 multiparametric 50 humanised monoclonal antibody 50 VASTox 50 CYT# potent vascular disrupting 50 Virulizin ® 50 UHCMC 50 dAbs 50 Proteomics 50 genomic alterations 50 GenPath 50 FOLOTYN ® 50 stapled peptides 50 clinical neurosciences 50 ProLindac TM 50 ProEthic 50 Angiocept 50 enzyme inhibitors 50 Sirius Genomics 50 immunosuppressive therapies 50 bluebird bio 50 FoldRx Pharmaceuticals Inc. 50 Nexavar ® 50 Immunotherapeutic 50 vemurafenib 50 CDP# 50 Etubics 50 Cogane 50 Addrenex 50 potent inhibitors 50 Epitome Biosystems 50 IL-#/# 50 comparative genomics 50 genetic variations 50 RNAi Therapeutics 50 NTDDS 50 Proteomic 50 epigenetic therapeutics 50 Bucindolol 50 therapeutic modalities 50 small molecule modulators 50 CYT# novel 50 hematologic oncology 50 novel anti infective 50 Agios Pharmaceuticals 50 protein biomarker 50 ophthalmic therapeutics 50 immunostimulants 50 deacetylase inhibitors 50 EGFR inhibitors 50 Maraganore 50 epigenetic regulation 50 Paramount BioSciences 50 therapeutic mAbs 50 BrainCells 50 anti infective 50 pharmacogenetic test 50 LHRH antagonists 50 ATL# [001] 50 Provectus Pharmaceuticals specializes 50 inhibit EGFR 50 antiangiogenic agents 50 immunotherapy 50 metabolomics driven 50 siRNA delivery 50 anti angiogenic agents 50 Akebia Therapeutics 50 pharmacotherapeutic 50 ophthalmology dermatology cardiovascular disease 50 neuroactive 50 GSK# [002] 50 MabThera rituximab 50 Fc gamma receptor 50 biologic treatments 50 Velcura 50 renal anemia 50 genetic loci 50 Oxford Genome Sciences 50 ProNAi 50 immunoregulatory 50 TMEM#B 50 neurogenetics 50 histone deacetylase inhibitors 50 drug metabolizing enzymes 50 trastuzumab Herceptin 50 Elixir Pharmaceuticals 50 purinergic receptors P#X# 50 interventional pulmonology 50 MolecularMD 50 Lu AA# 50 TARIS Biomedical 50 neuropsychiatric disorders 50 KRAS oncogene 50 insulin analogs 50 ProMune 50 Onconase 50 NPM1 50 ASPIRE HIGHER 50 Genedata 50 PIK3CA 50 PDE4 inhibitor 50 mitochondrial disorders 50 neuro inflammatory 50 JAK2 inhibitors 50 Ambrx 50 Genentech Herceptin 50 telomerase activation 50 radezolid 50 pharmacoeconomics 50 Lupuzor 50 oncology immunology 50 resolvin 50 Biological Complexity 50 TLR agonists 50 GeneSightRx 50 trastuzumab Herceptin ® 50 staphylococcal vaccine 50 antithrombotic agents 50 teplizumab 50 selective inhibition 50 Kari Stefansson CEO 50 bio similars 50 AZILECT ® 50 Avila Therapeutics 50 Martin Nicklasson CEO 50 biologicals 50 HERmark assay 50 bioanalysis 50 agomelatine 50 pathogenetic mechanisms 50 Diasome 50 Glybera R 50 novel immunotherapies 50 oncology infectious diseases 50 optical biosensors 50 multiplex assay 50 Oxford Immunotec 50 fusion enhancers 50 antitumoral 50 psoriasis rheumatoid arthritis 50 microbial pathogenesis 50 histone deacetylase HDAC inhibitors 50 CB2 receptor 50 Profectus BioSciences 50 torezolid phosphate 50 thalidomide Thalomid 50 Dr. Von Hoff 50 antithrombotics 50 ClinTec International 50 proteasome inhibitor 50 translational biomedical 50 microRNA profiling 50 Genaissance 50 antiinfective 50 Clofarabine 50 Hsp# inhibition 50 Micromet BiTE 50 multiple sclerosis psoriasis 50 integrase inhibitors 50 imatinib Gleevec 50 vinca alkaloid 50 G Protein Coupled 50 regenerative medicine 50 Regenerative medicine 50 K RAS 50 cellular immunotherapy 50 Numerate 50 pathophysiological mechanisms 50 inherited metabolic disorders 50 Charlesson 50 Sphingomab 50 anti infectives 50 Bexion 50 EraGen 50 QbD 50 validate biomarkers 50 therapeutic modality 50 DPX Survivac 50 QTL mapping 50 LEUKINE 50 siRNA compounds 50 Anidulafungin 50 BCR ABL inhibitors 50 AlloMap testing 50 molecularly targeted therapy 50 AvalonRx R 50 galectin 3 50 chemopreventive agent 50 commercialize deforolimus 50 pharmacologic treatments 50 NanoCrystal technology 50 BiTE 50 pediatric bipolar disorder 50 NNRs 50 kinase profiling 50 mGluR5 antagonist 50 γ secretase 50 non alcoholic steatohepatitis 50 mammalian genetics 50 Tasimelteon 50 Molecular imaging 50 FTIs 50 angiogenesis inhibition 50 dexpramipexole 50 Kleanthis G. Xanthopoulos Ph.D. 50 Anavex #-# 50 AEG# 50 Lambris 50 Abiraterone 50 Pyridorin 50 Simcyp 50 hematopathology 50 atopic march 49 Therapeutic Targets 49 Phylomer ® 49 pharmaco 49 genetic epidemiology 49 TTR amyloidosis 49 rxRNA compounds 49 aTyr Pharma 49 NuMimetic TM 49 microbial genomics 49 TACI Ig 49 anti infective therapeutic 49 beta secretase inhibitors 49 AttoSense 49 Aurora kinase inhibitors 49 Pancreate 49 Neurotherapeutics 49 biphosphonates 49 nanomedical 49 dasatinib Sprycel 49 AviaraDx 49 Li Fraumeni 49 Proneuron 49 protease inhibitors 49 CoLucid 49 AclarusDx 49 ParAllele 49 immune modulation 49 TransMolecular 49 biotechnologies 49 selective estrogen receptor modulator 49 Decision Biomarkers 49 MDx 49 TLR9 agonists 49 Nexrutine 49 mda 7 49 ZFP technology 49 therapeutic 49 cytochrome P# inhibition 49 Muckle Wells 49 ATD TM gel 49 Autoimmune Disease 49 Elvitegravir 49 rEEG 49 midstage clinical 49 Dyax phage display 49 essential thrombocythemia 49 CEQ# 49 p#/CBP 49 YONDELIS R 49 Proteostasis 49 malaria parasite genome 49 cediranib 49 kinase inhibition 49 ticagrelor Brilinta 49 Inflammatory diseases 49 ophthalmology oncology 49 Asthma COPD 49 ibudilast 49 enzastaurin 49 CDRD 49 Revimmune TM 49 EnzymeRx 49 thetreatment 49 allosteric modulation 49 neurodegenerative disease 49 Personalized Medicine 49 MyVax R 49 Revlimid lenalidomide 49 Carfilzomib 49 small molecule inhibitors 49 beta interferons 49 Cardio Vascu Grow 49 therapeutically useful 49 BioLeap 49 dermatological disorders 49 Metabolomics 49 Davanat 49 gamma secretase inhibitors 49 dietary interventions 49 Shire HGT 49 antisense compounds 49 aminoglycosides 49 Capsulution 49 TriGrid 49 PDGF receptor 49 protein ligand interactions 49 delafloxacin 49 Tranzyme 49 muscular dystrophies 49 romazarit 49 Cambria Biosciences 49 KRAS variant 49 ANAVEX 49 Kinase inhibitors 49 anti infective treatments 49 SiMoA 49 ixabepilone 49 stem cell differentiation 49 NexACT ® 49 dysbindin gene 49 Ostabolin C TM 49 NEUGENE 49 phenotyping 49 selective kinase inhibitor 49 peptidomimetic 49 CYP#D# gene 49 antisense inhibitor 49 Pseudomonas aeruginosa infections 49 ADME 49 genetics molecular biology 49 immuno inflammatory 49 Salugen 49 SNT MC# 49 antagomirs 49 Melior Discovery 49 antiangiogenesis 49 cancer immunotherapies 49 Neurodegenerative Diseases 49 EGFR mutation status 49 Anticalins 49 Cancidas 49 Quark Biotech Inc. 49 Lodamin 49 ToleroMune 49 subdisciplines 49 Immunopharmacology 49 BRACAnalysis 49 Cardiotoxicity 49 leukotriene receptor antagonist 49 pan HDAC inhibitor 49 Spiegelmers 49 vidofludimus 49 biosimulation 49 PI3K AKT 49 Lightlake 49 Calistoga Pharmaceuticals 49 targeted resequencing 49 antisense drugs 49 hereditary emphysema 49 tremelimumab 49 regenerative therapies 49 Eli Lilly Cymbalta 49 CCR1 49 Perlegen 49 ERYtech Pharma 49 echinocandin 49 dermatologic diseases 49 Molecular Profiling 49 CYP#C# [002] 49 targeted radiotherapeutic 49 bioinformatic